Does conversion of immunosuppressive monotherapy from cyclosporine A to tacrolimus improve bone mineral density in long-term stable liver transplant recipients?

Transplantation Proceedings

Volumn 35, Issue 8, 2003, Pages 3032-3034

  Ott, R ^a   Bussenius Kammerer, M ^b   Koch, C A ^a   Yedibela, S ^c   Kissler, H ^c   Hohenberger, W ^c   Muller V ^c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Knappschafts Krankenhaus Puettlingen   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ARTICLE; BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMUR NECK; GRAFT REJECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; LUMBAR SPINE; MALE; MONOTHERAPY; PRIORITY JOURNAL;

EID: 0347761579     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2003.10.028     Document Type: Article

References (8)

1. Kanis J.A., Melton L.J., Christiansen C., et al. J Bone Miner Res. 9:1994;1137.
2. Ahmed A.I., Blake G.M., Rymer J.M., et al. Osteoporos Int. 75:1997;432.
3. Hussaini S.H., Oldroyd B., Stewart S.P., et al. Eur J Gastroenterol Hepatol. 11:1999;157.
4. Lopez M.B., Gonzalez Pinto I., Hawkins F., et al. Transplant Proc. 24:1992;3044.
5. Cvetkovic M., Mann G.N., Romero D.F., et al. Transplantation. 57:1994;1231.
6. Park K.M., Hay J.E., Lee S.G., et al. Transplant Proc. 28:1996;1738.
7. Goodman G.R., Dissanayake I.R., Sodam B.R., et al. J Bone Miner Res. 16:2001;72.
8. Inoue T., Kawamura I., Matsuo M., et al. Transplantation. 70:2000;774.